Related Experiment Video
Updated: May 4, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis
Trang T Pham1, Steven P Angus1, Gary L Johnson1
1Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Abstract:
MAP3K1 is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family of serine/threonine kinases. MAP3K1 regulates JNK activation and is unique among human kinases in that it also encodes an E3 ligase domain that ubiquitylates c-Jun and ERK1/2. Full length MAP3K1 regulates cell migration and contributes to pro-survival signaling while its caspase 3-mediated cleavage generates a C-terminal kinase domain that promotes apoptosis. The critical function of MAP3K1 in cell fate decisions suggests that it may be a target for deregulation in cancer. Recent large-scale genomic studies have revealed that MAP3K1 copy number loss and somatic missense or nonsense mutations are observed in a significant number of different cancers, being most prominent in luminal breast cancer. The alteration of MAP3K1 in diverse cancer types demonstrates the importance of defining phenotypes for possible therapeutic targeting of tumor cell vulnerabilities created when MAP3K1 function is lost or gained.
Insights
Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) plays dual roles in cell survival and apoptosis. Alterations in MAP3K1 are linked to various cancers, highlighting its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- MAP3K1 is a serine/threonine kinase regulating JNK activation.
- It possesses a unique E3 ligase domain, ubiquitylating c-Jun and ERK1/2.
- Full-length MAP3K1 promotes cell migration and survival, while cleaved forms induce apoptosis.
Purpose of the Study:
- To investigate the role of MAP3K1 in cell fate decisions.
- To explore MAP3K1 as a potential therapeutic target in cancer due to its deregulation.
Main Methods:
- Analysis of MAP3K1's kinase and E3 ligase activities.
- Investigation of MAP3K1's role in cell migration and apoptosis.
- Review of large-scale genomic studies on MAP3K1 alterations in cancer.
Main Results:
- MAP3K1 copy number loss and mutations are prevalent in various cancers, notably luminal breast cancer.
- MAP3K1's dual function in cell survival and apoptosis is critical for cell fate.
- Cancer-associated MAP3K1 alterations create vulnerabilities exploitable for therapy.
Conclusions:
- MAP3K1's critical role in cell fate makes it a significant factor in cancer development.
- Understanding MAP3K1's altered functions in cancer is crucial for developing targeted therapies.
- Targeting tumor cell vulnerabilities arising from MAP3K1 loss or gain is a promising therapeutic strategy.
Related Concept Videos
02:23Abnormal Proliferation
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...